:

Insija Ilyas Selene1, Merve Ozen2, Reema A Patel2

  • 1Department of Medical Oncology, University of Kentucky College of Medicine, Lexington, Kentucky.

概括

针对晚期肝细胞癌 (HCC) 的全身疗法正在发展. 像阿特佐利祖马布/贝瓦西祖马布这样的免疫疗法组合显示出更好的结果,将治疗模式转移到传统的向疗法之外.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K